| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 57.08B | 58.41B | 57.28B | 61.57B | 59.70B | 58.68B |
| Gross Profit | 9.34B | 9.86B | 8.97B | 8.47B | 6.51B | 8.35B |
| EBITDA | 7.77B | 5.91B | 5.91B | 6.29B | 3.63B | 3.29B |
| Net Income | 2.89B | 3.13B | 1.25B | 1.27B | -418.00M | -951.00M |
Balance Sheet | ||||||
| Total Assets | 81.36B | 84.91B | 82.00B | 80.14B | 74.48B | 73.31B |
| Cash, Cash Equivalents and Short-Term Investments | 12.08B | 11.96B | 11.50B | 10.65B | 8.41B | 8.85B |
| Total Debt | 13.82B | 16.39B | 14.04B | 16.24B | 13.82B | 13.40B |
| Total Liabilities | 38.26B | 38.95B | 40.26B | 40.11B | 37.41B | 36.57B |
| Stockholders Equity | 43.10B | 45.96B | 41.73B | 40.03B | 36.86B | 36.33B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -1.41B | 2.94B | 1.93B | -171.00M | -1.15B |
| Operating Cash Flow | 0.00 | 2.05B | 6.15B | 4.88B | 2.81B | 3.50B |
| Investing Cash Flow | 0.00 | -3.22B | -2.73B | -3.08B | -2.80B | -4.70B |
| Financing Cash Flow | 0.00 | 1.32B | -2.84B | 292.00M | -686.00M | -675.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥92.95B | 17.18 | 7.00% | 3.02% | 8.49% | -0.33% | |
69 Neutral | ¥15.71B | 5.06 | ― | 3.41% | 1.98% | 150.85% | |
67 Neutral | ¥33.78B | 63.72 | ― | 1.17% | 24.89% | 26.18% | |
66 Neutral | ¥30.52B | 14.25 | ― | 2.13% | 0.12% | 59.33% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥35.15B | 28.39 | ― | 3.56% | -2.79% | -35.37% | |
58 Neutral | ¥6.69B | 4.45 | ― | 1.37% | -5.11% | 29.29% |